Publications - 'T'
Publications 2151 - 2175 de 2944
| Titre | DOI |
|---|---|
|
Tocilizumab failure in malignancy -related polymyalgia rheumatica E. Toussirot; S. Govindaraju; A. Mekinian 2020 |
10.1016/j.jbspin.2019.12.001 |
|
TOCILIZUMAB FOR REFRACTORY DYSTHYROID MYOPATHY (RDM) : A MONOCENTER OBSERVATIONAL STUDY OF 8 PATIENTS P. Bielefeld; F. Baudin; J. Blanc; A. Bron; S. Mouries-Martin; R. Bouvet; H. Devilliers 2019 |
10.1136/annrheumdis-2019-eular.2847 |
|
Tocilizumab for the Management of Corticosteroid-Resistant Mild to Severe Graves' Ophthalmopathy, a Report of Three Cases T. Maldiney; C. Deschasse; P. Bielefeld 2020 |
10.1080/09273948.2018.1545914 |
|
Tocilizumab in Giant Cell Arteritis: A Multicentre Open-Label Study in France A. Regent; S. Redeker; A. Deroux; P. Kieffer; K.Heang Ly; M. Dougados; C. Larroche; L. Guillevin; L. Bouillet; O. Espitia; N. Costedoat-Chalumeau; M. Soubrier; B. Brihaye; F. Lifermann; G. Lefevre; X. Puechal; L. Mouthon; E. Toussirot; GFEV; CRI 2015 |
|
|
Tocilizumab in Giant Cell Arteritis: A Multicentre Open-Label Study in France A. Regent; S. Redeker; A. Deroux; P. Kieffer; K.Heang Ly; M. Dougados; C. Larroche; L. Guillevin; L. Bouillet; O. Espitia; N. Costedoat-Chalumeau; M. Soubrier; B. Brihaye; F. Lifermann; G. Lefevre; X. Puechal; L. Mouthon; E. Toussirot; GFEV; CRI 2015 |
|
|
Tocilizumab in giant cell arteritis: a multicentre open-label study of 34 patients A. Regent; S. Redeker; A. Deroux; P. Kieffer; K. Ly; M. Dougados; E. Liozon; C. Larroche; L. Guillevin; L. Bouillet; O. Espitia; N. Costeodat-Chalumeau; M. Soubrier; B. Brihaye; F. Liferman; G. Lefevre; X. Puechal; L. Mouthon; E. Toussirot 2016 |
|
|
TOCILIZUMAB IN GIANT CELL ARTERITIS: A MULTICENTRE OPEN-LABEL STUDY OF34 PATIENTS A. Regent; S. Redeker; A. Deroux; P. Kieffer; K. Ly; M. Dougados; L. Eric; C. Larroche; L. Guillevin; L. Bouillet; O. Espitia; N. Costedoat-Chalumeau; M. Soubrier; B. Brihaye; F. Liferman; G. Lefebvre; X. Puechal; L. Mouthon; E. Toussirot 2016 |
10.1136/annrheumdis-2016-eular.4722 |
|
Tocilizumab in severe and refractory non-infectious uveitis M. Papo; P. Bielefeld; H. Vallet; P. Seve; B. Wechsler; P. Cacoub; P. Le Hoang; T. Papo; B. Bodaghi; D. Saadoun 2014 |
|
|
Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice C. Fortunet; Y.M. Pers; J. Lambert; M. Godfrin-Valnet; E. Constant; H. Devilliers; P. Gaudin; C. Jorgensen; B.Pallot Prades; D. Wendling; J.Francis Maillefert 2015 |
10.1093/rheumatology/keu339 |
|
Toeplitz band matrices with small random perturbations J. Sjostrand; M. Vogel 2021 |
10.1016/j.indag.2020.09.001 |
|
Tofacitinib as salvage therapy for patients hospitalized with refractory severe active ulcerative colitis: a GETAID multicenter prospective/retrospective cohort M. Uzzan; C. Bresteau; D. Laharie; C. Stefanescu; F. Carbonnel; M. Serrero; S. Viennot; M. Nachury; A. Amiot; R. Altwegg; L. Picon; S. Nahon; L. Vuitton; A. Soune; J. Kirchgesner; L. Peyrin-Biroulet; Y. Bouhnik 2021 |
10.1093/ecco-jcc/jjab076.397 |
|
Tofacitinib Enhanced Cerebral Brain-derived Neurotrophic Factor Levelsin a Rat Model of Rheumatoid Arthritis A. Quirie; C. Prati; D. Wendling; P. Totoson; C. Demougeot; C. Marie 2019 |
|
|
Tofacitinib Enhanced Cerebral Brain-derived Neurotrophic Factor Levelsin a Rat Model of Rheumatoid Arthritis A. Quirie; C. Prati; D. Wendling; P. Totoson; C. Demougeot; C. Marie 2019 |
|
|
Tofacitinib exhibits vascular and cerebral benefits in rat adjuvant-induced arthritis P. Totoson; A. Quirie; M. Pedard; M. Cefis; A. Prigent–Tessier; C. Prati; M. Tournier; C. Marie; C. Demougeot 2021 |
|
|
Tofacitinib improved peripheral endothelial dysfunction and brain-derived neurotrophic factor levels in the rat adjuvant-induced arthritis model P. Totoson; C. Peyronnel; A. Quirie; M. Pedard; M. Cefis; L. Bermont; A. Prigent-Tessier; C. Prati; M. Tournier; D. Wendling; C. Marie; C. Demougeot 2022 |
10.1111/fcp.12731 |
|
TOFACITINIB REVERSED ENDOTHELIAL DYSFUNCTION IN RHEUMATOID ARTHRITIS: MECHANISTIC INSIGHTS FROM THE RAT ADJUVANT-INDUCED ARTHRITIS MODEL P. Totoson; C. Prati; D. Wendling; A. Quirie; C. Marie; C. Demougeot 2020 |
10.1136/annrheumdis-2020-eular.2747 |
|
Token-Based Lightweight Authentication to Secure IoT Networks M. Dammak; O.Rafik Mera Boudia; M.Ayoub Messous; S.Mohammed Senouci; C. Gransart 2019 |
|
|
Token-Based Lightweight Authentication to Secure IoT Networks M. Dammak; O.Rafik Mera Boudia; M.Ayoub Messous; S.Mohammed Senouci; C. Gransart 2019 |
|
|
TOL19-001 reduces inflammation and MMP expression in monolayer cultures of tendon cells C. Bauge; S. Leclercq; T. Conrozier; K. Boumediene 2015 |
10.1186/s12906-015-0748-7 |
|
Tolerability of olaparib (OLA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations: PROfound G. Roubaud; M. Ozguroglu; N. Penel; N. Matsubara; N. Mehra; M.P. Kolinsky; G. Procopio; S. Feyerabend; J.Y. Joung; G. Gravis; K. Nishimura; C. Gedye; C. Padua; N. Shore; A. Thiery-Vuillemin; C. Gresty; N. Brickel; J. Burgents; A. Allen; K. Fizazi 2020 |
10.1016/j.annonc.2020.08.883 |
|
Tolerance and efficacy of antifibrotic treatments in IPF patients carriying telomere related gene mutations A. Justet; D. Klay; V. Cottin; M.Molina Molina; H. Nunes; M. Reynaud-Gaubert; J.M. Naccache; E. Manali; A. Froidure; S. Jouneau; L. Wemeau; C. Andrejak; A. Gondouin; S. Hirschi; B. Bondue; P. Bonniaud; C. Tromeur; G. Prevost; S. Marchand-Adam; M. Funke-Chambour; A.S. Gamez; C. Kanengiesser; C. van Moorsel; B. Crestani; R. Borie 2019 |
10.1183/13993003.congress-2019.OA2140 |
|
Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey L. Rossi-Semerano; B. Fautrel; D. Wendling; E. Hachulla; C. Galeotti; L. Semerano; I. Touitou; I. Kone-Paut; M.A.I.L.1Study Grp; CRI 2015 |
10.1186/s13023-015-0228-7 |
|
Toll-like receptor 5 deficiency exacerbates cardiac injury and inflammation induced by myocardial ischaemia-reperfusion in the mouse R. Parapanov; J. Lugrin; N. Rosenblatt-Velin; F. Feihl; B. Waeber; G. Milano; C. Vergely; N. Li; P. Pacher; L. Liaudet 2015 |
10.1042/CS20140444 |
|
Tomorrow's ultrasound imaging: When ultrasound systems become ultra-fast E.G. Simon; S. Calle; J.P. Remenieras 2019 |
10.1016/j.gofs.2019.03.014 |
|
Tongue Leptin Decreases Oro-Sensory Perception of Dietary Fatty Acids H. Ullah; A.Sayed Khan; B. Murtaza; A. Hichami; N.Akhtar Khan 2022 |
10.3390/nu14010197 |